Asthma and Chronic Obstructive Pulmonary Disease Overlap According to the Japanese Respiratory Society Diagnostic Criteria: The Prospective, Observational ACO Japan Cohort Study

Overview

Journal Adv Ther

Date 2020 Dec 28

PMID 33355907

Citations 11

Authors

Shu Hashimoto

Ryoko Sorimachi

Tatsunori Jinnai

Masakazu Ichinose

Affiliations

Soon will be listed here.

Abstract

Introduction: Patients with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) present with chronic respiratory symptoms with features of both asthma and COPD. New ACO diagnostic criteria (2018) were suggested by the Japanese Respiratory Society (JRS). This prospective, multicenter, observational cohort study was conducted to investigate the proportion of patients who meet the JRS ACO diagnostic criteria among COPD patients in clinical practice.

Methods: This 2-year ongoing study enrolled consecutive outpatients aged ≥ 40 years with COPD who visited one of 27 Japanese centers at which the medical examinations/tests required for ACO diagnosis were routinely conducted. At registration, the proportion of ACO or non-ACO patients was determined using the JRS diagnostic criteria, and the characteristics of the two groups were compared using analysis of variance and chi-square test.

Results: Of 708 COPD patients analyzed at registration, 396 (55.9%) had the data necessary for ACO diagnosis to be conducted, and 312 (44.1%) were lacking these data. Of the 396 patients who had the data necessary for ACO diagnosis, 101 (25.5%) met the diagnostic criteria for ACO, and 295 (74.5%) did not (non-ACO patients). ACO patients were younger, had a greater rate of asthma based on a physician's diagnosis, and used more medications, including inhaled corticosteroids (p < 0.05), compared with non-ACO patients.

Conclusions: We have determined the proportion of patients with the data necessary to diagnose ACO using the JRS criteria, and the proportion of these who met the ACO criteria among the COPD population at the time of registration. Patients, including those lacking necessary examination/test data at registration, will continue to undergo follow-up to explore changes in their testing and ACO diagnostic status over time. Analyses of study data over 2 years will provide relevant information on the ACO symptoms, clinical course, and real-world treatment patterns.

Trial Registration: ClinicalTrials.gov identifier, NCT03577795.

Citing Articles

Real-World Treatment Patterns and Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease in Japan: The REMIND Study.

Gon Y, Sorimachi R, Yoshida Y, Tamai Y, Takashima I, Arita Y Adv Ther. 2024; 41(9):3585-3597.

PMID: 39046695 PMC: 11349777. DOI: 10.1007/s12325-024-02927-5.

Fractional exhaled nitric oxide distribution and its relevant factors in the general adult population and its healthy subpopulation.

Yamada M, Takase M, Nakaya K, Nakamura T, Kogure M, Nakaya N J Allergy Clin Immunol Glob. 2024; 3(3):100253.

PMID: 38745867 PMC: 11090912. DOI: 10.1016/j.jacig.2024.100253.

Underdiagnosis of COPD: The Japan COPD Real-World Data Epidemiological (CORE) Study.

Koga Y, Deguchi S, Matsuo T, Suzuki A, Terashima G, Tajima T Int J Chron Obstruct Pulmon Dis. 2024; 19:1011-1019.

PMID: 38737192 PMC: 11088415. DOI: 10.2147/COPD.S450270.

Sputum microbiota and inflammatory subtypes in asthma, COPD, and its overlap.

Morimoto C, Matsumoto H, Nomura N, Sunadome H, Nagasaki T, Sato S J Allergy Clin Immunol Glob. 2023; 3(1):100194.

PMID: 38155860 PMC: 10753087. DOI: 10.1016/j.jacig.2023.100194.

COPD Patients with Asthma Features in Vietnam: Prevalence and Suitability for Personalized Medicine.

Van Tho N, Phan T, Dinh-Xuan A, Ngo Q, Lan L J Pers Med. 2023; 13(6).

PMID: 37373890 PMC: 10302634. DOI: 10.3390/jpm13060901.

References

Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K . Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Respirology. 2015; 20(6):940-6. DOI: 10.1111/resp.12556. View

Tiotiu A . Biomarkers in asthma: state of the art. Asthma Res Pract. 2019; 4:10. PMC: 6302401. DOI: 10.1186/s40733-018-0047-4. View

Pascoe S, Locantore N, Dransfield M, Barnes N, Pavord I . Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015; 3(6):435-42. DOI: 10.1016/S2213-2600(15)00106-X. View

Yamamura K, Hara J, Kobayashi T, Ohkura N, Abo M, Akasaki K . The prevalence and clinical features of asthma-COPD overlap (ACO) definitively diagnosed according to the Japanese Respiratory Society Guidelines for the Management of ACO 2018. J Med Invest. 2019; 66(1.2):157-164. DOI: 10.2152/jmi.66.157. View

Barnes P . Cellular and molecular mechanisms of asthma and COPD. Clin Sci (Lond). 2017; 131(13):1541-1558. DOI: 10.1042/CS20160487. View

Izquierdo-Alonso J, Rodriguez-Gonzalezmoro J, de Lucas-Ramos P, Unzueta I, Ribera X, Anton E . Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Respir Med. 2013; 107(5):724-31. DOI: 10.1016/j.rmed.2013.01.001. View

Yanagisawa S, Ichinose M . Definition and diagnosis of asthma-COPD overlap (ACO). Allergol Int. 2018; 67(2):172-178. DOI: 10.1016/j.alit.2018.01.002. View

Fu J, Gibson P, Simpson J, McDonald V . Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2013; 87(1):63-74. DOI: 10.1159/000352053. View

Tamada T, Sugiura H, Takahashi T, Matsunaga K, Kimura K, Katsumata U . Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015; 10:2169-76. PMC: 4608617. DOI: 10.2147/COPD.S88274. View

10.

Jenkins C, FitzGerald J, Martinez F, Postma D, Rennard S, van der Molen T . Diagnosis and management of asthma, COPD and asthma-COPD overlap among primary care physicians and respiratory/allergy specialists: A global survey. Clin Respir J. 2019; 13(6):355-367. DOI: 10.1111/crj.13016. View

11.

Leung J, Sin D . Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets. BMJ. 2017; 358:j3772. DOI: 10.1136/bmj.j3772. View

12.

Kitaguchi Y, Yasuo M, Hanaoka M . Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation. Int J Chron Obstruct Pulmon Dis. 2016; 11:991-7. PMC: 4869610. DOI: 10.2147/COPD.S105988. View

13.

Cosio B, Soriano J, Lopez-Campos J, Calle-Rubio M, Soler-Cataluna J, de-Torres J . Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort. Chest. 2015; 149(1):45-52. DOI: 10.1378/chest.15-1055. View

14.

Alshabanat A, Zafari Z, Albanyan O, Dairi M, Fitzgerald J . Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. PLoS One. 2015; 10(9):e0136065. PMC: 4559416. DOI: 10.1371/journal.pone.0136065. View

15.

Park S, Jung H, Kim J, Seo B, Kwon O, Choi S . Longitudinal analysis to better characterize Asthma-COPD overlap syndrome: Findings from an adult asthma cohort in Korea (COREA). Clin Exp Allergy. 2019; 49(5):603-614. DOI: 10.1111/cea.13339. View

16.

Inoue H, Nagase T, Morita S, Yoshida A, Jinnai T, Ichinose M . Prevalence and characteristics of asthma-COPD overlap syndrome identified by a stepwise approach. Int J Chron Obstruct Pulmon Dis. 2017; 12:1803-1810. PMC: 5490467. DOI: 10.2147/COPD.S133859. View

17.

Rogliani P, Ora J, Puxeddu E, Cazzola M . Airflow obstruction: is it asthma or is it COPD?. Int J Chron Obstruct Pulmon Dis. 2016; 11:3007-3013. PMC: 5137932. DOI: 10.2147/COPD.S54927. View

18.

Lange P, Colak Y, Ingebrigtsen T, Vestbo J, Marott J . Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med. 2016; 4(6):454-62. DOI: 10.1016/S2213-2600(16)00098-9. View

19.

Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society . The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med. 2006; 45(7):419-28. DOI: 10.2169/internalmedicine.45.1691. View

20.

Uchida A, Sakaue K, Inoue H . Epidemiology of asthma-chronic obstructive pulmonary disease overlap (ACO). Allergol Int. 2018; 67(2):165-171. DOI: 10.1016/j.alit.2018.02.002. View